Atovaquone

CAS 95233-18-4 10 current records 4 historicalSmall Molecule

Who holds supplier records for Atovaquone? 10 organisations hold a current record for Atovaquone: an active US FDA Type II Drug Master File or a CEP. A further 4 organisations have only historical (inactive) DMF filings. 5 of them hold a valid EU Certificate of Suitability. Recorded organisation countries for current records: India (8), China (1) and Israel (1).

Sources: FDA Drug Master File list, EDQM certification database, FDA Orange Book. Record updated 16 Nov 2026. How we read these records

Cite as: PharmaTek, “Atovaquone: DMF and CEP holder records”, record as of 16 Nov 2026, pharmatek.co.uk/directory/api/atovaquone

Reading the evidence

  • 10 current records

    Several organisations hold current DMFs or CEPs. Whether any is a usable source for your grade, scale and market still needs qualification.

  • Most recorded organisations are in India

    8 of the 10 current records with a recorded country list India. Organisation country is not necessarily the manufacturing site.

  • 6 with a company-level GMP certificate on record

    These organisations have at least one current EU or UK GMP certificate somewhere. It is not matched to the site that makes this substance; check the certificate's site and scope.

Current records (10)

Organisations holding an active US FDA Type II Drug Master File or a CEP for Atovaquone. Country is the organisation's recorded country, not necessarily the manufacturing site.

Need Atovaquone sourced and checked?

The Sourcing Desk contacts candidates, confirms current supply, grade and site, and screens each against its regulatory record, for a buyer-paid fixed fee and never a supplier commission.

Request sourcing help

Valid CEP holder entries (5)

Certificates of Suitability on the EDQM register for Atovaquone, including the salts, esters and hydrates the register lists separately; each row shows the substance as named on the certificate. A CEP confirms the substance can be controlled by the European Pharmacopoeia monograph; it is not a GMP certificate, and the holder is not necessarily the manufacturer. 8 certificates in total, including withdrawn, expired, suspended and repeat certificates.

HolderCountryCertificateIssuedEU GMP at holder's address
IPCA LABORATORIES LIMITED MumbaiIN
CEP 2021-107 - Rev 03
Atovaquone
Oct 2026—
ALIVUS LIFE SCIENCES LIMITED MumbaiIN
CEP 2015-346 - Rev 03
Atovaquone
May 2026—
HETERO DRUGS LIMITED HyderabadIN
CEP 2025-001 - Rev 01
Atovaquone, Form A, Process-II
Apr 2026—
MATRIX PHARMACORP PRIVATE LIMITED Sangareddy DistrictIN
CEP 2013-194 - Rev 04
Atovaquone
Sept 2025—
APITORIA PHARMA PRIVATE LIMITED HyderabadIN
CEP 2018-136 - Rev 03
Atovaquone
Jul 2024—

The GMP column shows the most recent EU GMP certificate issued for the same address as the holder, joined on the EMA location identifier printed on both documents (EudraGMDP, re-read about once a quarter; withdrawn certificates are excluded). A dash means no certificate carries that identifier, not that the site is uninspected. The holder's address is not necessarily where the substance is made.

Certification Online Database. European Directorate for the Quality of Medicines & HealthCare (EDQM), Council of Europe, (2026), URL: https://extranet.edqm.eu/publications/recherches_CEP.shtml. Accessed 16 Nov 2026. Reproduced with permission and unaltered. The EDQM and the Council of Europe accept no liability for any consequence arising from its use.

Historical records (4)

Organisations whose Type II DMFs for Atovaquone are no longer active. These show a past filing, not current supply.

Show all 4 historical records

Overview

Atovaquone is a small molecule active pharmaceutical ingredient (ChEMBL CHEMBL1450).

Pharmacologic class

As the US FDA states it for this active substance on product listings.

Established pharmacologic class
Antimalarial; Antiprotozoal

Record history

No change to the current records between 13 Nov 2026 and 16 Nov 2026.

Get an email when these records change: at most one a week, only when something changed, and only after you confirm your address. All changes this week

What these records establish

  • An active DMF means a confidential file is held by the FDA and can be referenced; the FDA does not approve or disapprove DMFs.
  • A CEP confirms monograph suitability for the EU market; it is not a GMP certificate, and the holder may not be the manufacturer.
  • Historical records show a past filing, not current supply.
  • Company GMP certificates are matched to the organisation, not to the site making this substance.
  • A substance missing from these registers is not evidence that no supplier exists.

Frequently asked questions

Which organisations hold current supplier records for Atovaquone?

10 organisations hold an active US FDA Type II Drug Master File or a CEP for Atovaquone: ALIVUS LIFE SCIENCES LTD (India), Hetero Drugs Limited (India), APITORIA PHARMA PRIVATE LTD (India), Ipca Laboratories Limited (India), MATRIX PHARMACORP PRIVATE LTD (India), ALCHYMARS ICM SM PRIVATE LTD (India), Nuray Chemicals Pvt. Ltd. (India) and Shanghai Desano Chemical Pharmaceutical Co., Ltd (China), and 2 more listed on this page. A DMF or CEP shows a regulatory filing, not current commercial availability, and the holder is not necessarily the manufacturing site.

Which Atovaquone Drug Master Files are active?

ALIVUS LIFE SCIENCES LTD (DMF 22121, 31142), Hetero Drugs Limited (DMF 24446, 40952), APITORIA PHARMA PRIVATE LTD (DMF 31675), Ipca Laboratories Limited (DMF 42201), MATRIX PHARMACORP PRIVATE LTD (DMF 22134), ALCHYMARS ICM SM PRIVATE LTD (DMF 22057), Nuray Chemicals Pvt. Ltd. (DMF 36339) and Shanghai Desano Chemical Pharmaceutical Co., Ltd (DMF 25305, 43622) and 2 more. The FDA does not approve or disapprove DMFs; an active DMF can be referenced in an application once its holder issues a letter of authorisation.

What do the historical Atovaquone records mean?

4 organisations have only inactive Type II DMFs for Atovaquone. An inactive DMF records that a filing once existed; it does not show that the organisation supplies the substance today.

Does Atovaquone have a European Certificate of Suitability?

Yes. 5 organisations hold a valid CEP for Atovaquone on the EDQM register, including IPCA LABORATORIES LIMITED Mumbai (IN), ALIVUS LIFE SCIENCES LIMITED Mumbai (IN), HETERO DRUGS LIMITED Hyderabad (IN), MATRIX PHARMACORP PRIVATE LIMITED Sangareddy District (IN) and APITORIA PHARMA PRIVATE LIMITED Hyderabad (IN). A CEP confirms the substance can be controlled by the European Pharmacopoeia monograph; it is not a GMP certificate, and the holder is not necessarily the manufacturer.

How do I qualify a Atovaquone supplier?

Confirm the DMF or CEP is current and covers your grade, obtain the letter of authorisation, identify the actual manufacturing site and check its GMP certificate and FDA inspection history, audit the site or review a recent audit, and run comparable requests for information across more than one candidate.

For suppliers

Do you supply Atovaquone?

Send a link to a certificate, registration or filing we have missed or got wrong. We check it against the issuing register before changing anything; information we cannot check against a register is shown as supplier-reported.

Free. Payment never buys an evidence status.